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Abstract
Objective: Links between secondhand smoke (SHS) exposure and cardiovascular disease in 
adults are well established but seldom reported during childhood. Although rates of smoking have 
decreased, young children from low-income backgrounds remain likely to be exposed to SHS. The 
purpose of this study was to investigate relationships between SHS exposure in young children and 
several preclinical markers of cardiovascular risk that have been established as relevant to adult 
populations.
Methods: 139 children, 2–5 years of age, were enrolled in a cross-sectional study. SHS exposure 
was objectively determined by hair nicotine level; a comprehensive panel of clinical markers (AM 
blood pressure, fasting glucose & insulin, lipid profiles, inflammation) and research markers 
(markers of oxidation, endothelial stress, and endothelial repair) of cardiovascular risk status were 
assessed. Univariate and multivariate linear regression were used to evaluate relationships between 
SHS exposure and cardiovascular risk markers.
Results: Hair nicotine levels were directly correlated with blood pressure and serum CRP, and 
inversely correlated with serum HDL and endothelial cell progenitor cell prevalence. In 
multivariate analyses, these relationships remained when controlled for age, sex, BMI z-score, 
maternal education, and method of payment. Additionally, in multivariate analyses, hair nicotine 
level was significantly negatively correlated with total anti-oxidant capacity.
Conclusions: These results support the view that SHS exposure in the very young has a 
detectable relationship with several markers of cardiovascular risk, long before the emergence of 
clinical disease. Further studies to define mechanisms and strategies to prevent and mitigate these 
risks early in life are warranted.
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BACKGROUND:
The latest CDC report shows that despite an overall reduction in secondhand smoke (SHS) 
exposure from 1999 to 2015, 25% of the US population remains exposed1. Of special 
concern are children from low-income homes and African-American children, since they 
have the highest rates of biologically measured SHS exposure1. Over 40% of US children 
aged 3–11 were exposed to tobacco smoke from 2011–2012, based on a biological marker of 
exposure, serum cotinine levels1. An inverse relationship between socioeconomic status and 
SHS exposure has been well documented2, 3, and recent analyses have shown that for every 
decrease in family income ratio, serum cotinine levels increased by 1.18 ng/L among 
children2. This evidence, coupled with a burden of lifetime exposure make young children of 
utmost concern. Better defining health risks of SHS in young children from low-income 
settings may help to underscore this health-risk disparity and help pediatricians to enhance 
strategies to mitigate these risks.
Links between SHS and cardiovascular disease (CVD) and death in adults are very well 
established4–7. SHS is a known risk factor for the development of atherosclerotic heart 
disease and increases the risk of CVD by about 30% in non-smoking adults5–7. In contrast to 
compelling evidence in adults studies demonstrating cardiovascular implications of SHS 
exposure during childhood are less defined. Young children are at particular risk for SHS 
exposure2, 8. More importantly, in our previous work, we demonstrated that toddlers had 
higher hair nicotine levels when compared to older children with equivalent survey measures 
of SHS exposure9.
A challenge for studying cardiovascular risk in pre-adulthood is the fact that children and 
adolescents very rarely exhibit clinical manifestations of acquired (non-congenital) heart 
disease. Most adult forms of cardiovascular disease are either related to or driven by 
inflammatory processes4, and such processes are apparently initiated in childhood. However, 
few studies have assessed the concurrent relationship between SHS exposure and 
cardiovascular risk markers in children younger than six years old10.
Our goal was to better define the relationship between SHS exposure in toddlers age 2–5 and 
preclinical cardiovascular disease risk. We investigated several surrogate markers of CVD 
risks in relation to SHS exposure and included traditional clinical measures as well as 
research measures recognized as relevant and mechanistically involved in adult settings. 
Clinical measures were blood pressure, glucose metabolism, blood lipids, and markers of 
inflammation, while ‘research measures’ were markers oxidation, and vascular endothelial 
stress and endothelial repair. Each of these indicators has been linked to SHS exposure and 
cardiovascular disease in adult or older pediatric populations7, 11–14 but has not been 
investigated in very young children. Prior studies have not focused on this age group where 
cardiovascular implications of SHS may be importantly under-recognized.
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METHODS:
Human Subject Recruitment:
The Nationwide Children’s Hospital (NCH) IRB approved of the study. Participants were 
children aged 2–5 years and parents provided informed consent. They were recruited via 
convenience sampling through recruiting in Nationwide Children’s Hospital Primary Care 
Network (Columbus, Ohio), and advertising via an internal hospital e-mail system. The 
Primary Care Network primarily serves low-income, urban children in Columbus. Inclusion 
criteria were healthy children both exposed and unexposed to SHS by parental report. 
Exclusion criteria were: the presence of one or more of the following: acute febrile illness or 
other active infections, congenital heart disease, diabetes (Type 1 or 2), elevated fasting 
glucose (>100 mg/dl), family history of elevated cholesterol, use of oral or inhaled (anti-
inflammatory) steroids within one month of testing, and/or not having enough hair for hair 
sampling of SHS exposure (hair nicotine level). This approach to enrollment thus avoided 
children with persistent asthma, because of the use of daily anti-inflammatories, which we 
considered confounding for this present study.
Study Procedures:
The study was introduced to the mother or caregiver at a clinic visit. Subjects were 
subsequently scheduled for testing at a research site in the morning between 8–10am, after 
overnight fasting. The protocol was carried out as follows: a) Study procedures were 
described with parental informed consent and youth/teen assent and consent obtained, b) 
anthropomorphic measurements obtained, c) structured interview with subject and parent 
(demographics and SHS exposure history), d) hair sample obtained and e) the blood sample 
of 7 ml was collected for biomarkers and covariates. After serum sample collection all 
assays were stored on ice and used within 12hrs of collection (24hr for flow cytometry 
studies).
Height, Weight, BMI:
Height and weight were obtained using a Tanita BWB800 scale and Seca stadiometer. 
Heights were measured to the nearest 0.5cm, weights to the nearest 0.1kg. BMI’s and z-
score norms were determined according to CDC guidelines (http://www.cdc.gov/
healthyweight/assessing/bmi/childrens_bmi/about_childrens_bmi.htmlref).
Measured variables:
We assessed a comprehensive panel of clinically relevant and research-based outcome 
variables that have been used by others to reflect cardiovascular status and related disease 
risks. Brief descriptions of methods and rationale are shown below. Additional analytical 
details are provided in online supplemental materials.
Secondhand smoke exposure:
Hair nicotine was used as a biological marker of SHS exposure to assess long-term 
evaluation of smoke exposure since the nicotine is incorporated into the growing hair shaft 
over several months. Samples are easy to obtain, handle, and store. Approximately 20–40 
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hair shafts from the occipital area were cut at the root and 2–3 cm in length. Hairs were 
stored and later sent for assay at an established contract research facility (Johns Hopkins 
School of Public Health). The hair nicotine assay involves washing the hair sample before 
analysis and therefore is designed to measure inhaled nicotine, and not ambient nicotine 
simply adhered to hair. Content is expressed as ng/mg of hair.
Blood pressure:
Blood pressure was measured via a Critikon-Dinamap Compact T monitor. The subject was 
fasting and allowed upright (typically in a parent’s lap) for at least 5 minutes, the 
measurement is taken on the subject’s left arm while. Normalized BP (percentile of 
normative values) was derived from NHLBI tables, accounting for height, age, and gender 
(http://www.nhlbi.nih.gov/guidelines/hypertension/child_tbl.htm).
Blood lipid profiles, glucose, insulin:
Fasting lipid profiles and glucose were measured via our hospital core lab facility. Insulin 
was determined by EIA (GenWay Biotech Inc. San Diego, CA, Cat# 40-056-205011).
Biomarkers of inflammation:
C-reactive protein (CRP): This was measured as a classical and clinically relevant 
measure of systemic inflammation that has been linked to SHS exposure in both adults and 
children11, 15. Elevations in serum CRP, and increased gene expression in the myocardium, 
have also been demonstrated in many forms of adult heart disease and is a strong 
independent predictor of CVD risk in adults16. This was measured using a commercially 
available enzyme immunoassay test kit (BioCheck, Inc, Foster City, CA; Cat # BC-1119). 
Intra- and inter- assay variations are less than 5 and 11%, respectively.
Serum IL-6 and TNF: These cytokines were measured as research-based markers of 
systemic inflammation. Both IL-6 and TNFα have been correlated with adiposity in children 
6–19 years of age. Association of these markers with SHS is less known, especially in young 
children. Plasma IL-6 levels were determined using a highly sensitive ELISA kit (R&D 
systems, Minneapolis, MN; Cat # DY206). Intra and inter- assay variations are less than 8 
and 10%, respectively.
Biomarkers of oxidation:
Protein malondialdehyde adducts: This is a measure of lipid peroxidation in serum17. 
Malondialdehyde is a highly reactive three-carbon dialdehyde byproduct of fatty acid 
peroxidation, which readily combines with several functional groups on molecules including 
proteins. We have found significant relationships between protein MDA and hair nicotine 
level in obese teenagers18. These were measured by OxiSelect™ MDA Adduct competitive 
ELISA kits from Cell Biolabs, INC, San Diego, CA (Cat#STA-832–5). The quantity of 
MDA adduct in samples was determined by comparing its absorbance with that of a 
predetermined MDA-BSA standard curve, and reported as pmol MDA/mL.
Total plasma anti-oxidant capacity: This measurement provides a non-specific 
measure of ‘antioxidant reserve’ in plasma and is thus an indication of the overall capability 
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to counteract reactive oxidizing species and combat oxidative stress related diseases. It has 
been shown to be reduced in many settings of chronic inflammation/oxidation19. Both small 
molecule and protein antioxidants are measured in aggregate, and results are presented as 
mM Trolox equivalents (a reference reagent with quantitative antioxidant capacity). 
Commercial assay kits were from Biovision Research Products (Cat#K274–100), Mountain 
View, CA. Cu++ was converted to Cu+ by both small molecules and protein antioxidants in 
plasma samples. The levels of reduced Cu+ ion were determined by the absorbance of a 
chelated colorimetric probe. Trolox was used as a standard antioxidant and total plasma 
antioxidant capacity was expressed as mM Trolox equivalents.
Biomarkers of vascular endothelial stress:
Soluble intercellular adhesion molecule-1 (s-ICAM1) was measured as a biomarker of 
endothelial stress and activation. Elevations in this marker have been documented in several 
settings of vascular injury (including coronary heart disease), and in relation to SHS 
exposure.13 Levels of s-ICAM-1 were determined using a sensitive commercially available 
ELISA kit (R&D systems, Minneapolis, MN; Cat # DY720). Intra and inter- assay variations 
are less than 5 and 10%, respectively.
Circulating endothelial progenitor cells (EPCs): EPCs are bone marrow–derived 
stem cells that have the ability to differentiate into functional endothelial cells, circulate in 
the blood and home preferentially to sites of vascular or tissue injury, contributing 
significantly to both endothelial repopulation and neovascularization20. These cells have 
been recognized as a potential surrogate biological marker for vascular function and 
cumulative cardiovascular risk in adults21, 22. Decreased EPC number and function have 
been shown in adult non-smokers exposed to SHS23 but have not been studied in 
relationship to SHS exposure in young children.
A volume of 50μL anticoagulated peripheral blood was incubated with 50μL 3% BSA in 
PBS (without Ca++ and Mg++) at room temperature for 30 min. In dark, fluorescence labeled 
antibodies (2.5μL of each), PE-CD133, FITC-CD34, and PECy5-CD45, were added and 
incubated for 30 min at room temperature. FACS lysis buffer (450μL) was then added, and 
incubated for 30min at room temperature in dark. Samples were then analyzed on FACS 
Caliber flow cytometer, where total counts were >400,000 cells. Prevalence of CD34+/
CD45-, CD133+/CD45-, or CD34+/CD133+/CD45- cells was expressed as the percentage 
of total events.
Statistical analyses:
Statistical analyses were performed with Stata 13.1 (StataCorp. 2013 Stata Statistical 
Software: Release 13.0; Stata Corporation, College Station, TX). A P value of 0.05 or less 
was considered statistically significant. Categorical variables were used to indicate sex 
(female=1, male=0); race (African American, White, Biracial, and Other Race); ethnicity 
(Hispanic or Latino=1, Non-Hispanic=0), insurance status (Medicaid benefits=1, All other 
insurance=0); maternal education (less than high school, high school graduate or GED, some 
college, or college graduate or higher).
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Continuous outcome variables were used for child’s systolic blood pressure, diastolic blood 
pressure, systolic blood pressure %, diastolic blood pressure %, total cholesterol, LDL, 
HDL, fasting glucose, fasting insulin, CRP, IL-6, TNF-α, plasma protein malondialdehyde, 
total anti-oxidant capacity, soluble iCAM-1, and EPC prevalence. In multivariate regression 
analysis, fasting insulin, CRP levels, Il-6, TNF-α, plasma protein malondialdehyde and EPC 
prevalence were logarithmically transformed to improve the distribution of these variables. 
Age and BMI were also modeled as continuous measures. BMI was converted to a BMI z-
score. A program available in Stata, zscore06 was used to calculate anthropometric z-scores. 
Length/height for-for-age, weight-for-height, BMI-for-age and weight-for-age Z-scores were 
calculated.
Bivariate associations between baseline demographic characteristics, SHS, and all 
cardiovascular outcomes were examined first using Pearson correlations. Multivariate linear 
regression with robust standard errors, clustered on family ID to account for the clustering of 
children within the same family was used to model each of the cardiovascular outcomes 
separately. All models included covariates for sex, race, ethnicity, insurance status, maternal 
education, age, and BMI z-score. Descriptive statistics are presented for all variables (means 
and SD for normally distributed and medians and interquartile ranges for skewed variables). 
Only significant models are presented for the multivariate models. Among the 149 children 
2–5 years of age that were included in the study, 10 had missing information on maternal 
education, with a final sample size n=139Additionally, eight children had missing 
information on systolic blood pressure, and systolic blood pressure % and 9 had missing 
values for EPC prevalence. The models for CRP and TAC each had one additional missing 
case. Since models were run separately by outcome, the final sample size for blood pressure 
was n=131, TAC n=138, CRP n=138 and for EPC n=122. All other models presented had 
the full sample, minus those missing maternal education, n=139. Sensitivity analysis has 
confirmed that there are no significant differences with or without missing cases.
RESULTS:
Population characteristics and sample distributions:
Characteristics of the study subjects are shown in Table 1. The average age was 3.2 yrs, and 
the majority (82%) was of lower socioeconomic status (insured through Medicaid), with a 
minority of mothers having a college degree or higher (14%). One-third of the group was 
either overweight (10.7%) or obese (22.8%).
Secondhand smoke exposure and hair nicotine levels:
The enrolled participants were highly smoke exposed (Table 1); 66.4% subjects lived with a 
smoker, and forty (26.8%) lived with 2 or more smokers. Maternal smoking was present in 
sixty-two (42.3%) of the enrolled subjects. Hair nicotine levels were not normally 
distributed, the median was 1.86ng/mg, with an average hair nicotine of 5.51 ng/mg (SD 
8.43), and a wide range of exposure levels from 0.03 ng/mg (virtually no exposure) to 39.45 
ng/mg.
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Table 2 presents the results of all outcome variables analyzed. Means and standard 
deviations are presented for the normally distributed variables, medians and interquartile 
ratios are presented for the variables with skewed distributions.
Simple bivariate analyses: SHS vs. other measured cardiovascular risk variables.
Preliminary bivariate analyses were performed using Pearson correlations, examining the 
associations between log-transformed hair nicotine vs. each other demographic and other 
measured variables (n=131–139 for each pairwise analysis). Log hair nicotine was 
significantly positively related to SBP (Pearson’s r= 0.21), SBP% (Pearson’s r= 0.30), and 
DPB (Pearson’s r=0.17), all significant at < 0.05. Additionally, log hair nicotine was 
inversely related to total cholesterol (Pearson’s r = −0.23) and HDL cholesterol (Pearson’s r 
= −0.23); both significant at the < 0.05 level. Log hair nicotine was significantly positively 
related to log CRP (Pearson’s r = 0.21), and negatively related to EPC prevalence (Pearson’s 
r = −28), both significant at the 0.05 level. There was no significant relationship between log 
hair nicotine and diastolic blood pressure percent, triglycerides, LDL and VLDL cholesterol, 
fasting glucose or insulin levels, IL6, TNFα, MDA, TAC, and s-ICAM1.
Multivariate regression analyses:
Separate multivariate linear regression analysis (clustered on family ID with robust standard 
errors) examined the relationship between log-transformed hair nicotine and all 
cardiovascular outcomes above. All models included controls for sex, age, race, ethnicity, 
method of payment, maternal education, and BMI z-score (Table 3). Log hair nicotine was 
independently significantly related to systolic blood pressure, systolic blood pressure 
percentile, HDL, CRP, TAC, and EPC prevalence. BMI z-score was also independently 
related to systolic blood pressure, systolic blood pressure percent, and HDL; however, no 
interaction effect was found between BMI and hair nicotine for any of the cardiovascular 
risk measures. Examining the clinical variables, each single log-increase in hair nicotine 
(corresponding to 2.72 ng/mg hair) was associated with an increase of 4.68 mm/Hg for 
systolic blood pressure, a 0.92 mg/L increase in CRP, and a 4.42 mg/dl decrease in HDL. 
Regarding the research variables, each log-increase of hair nicotine was associated with a 
decrease of 0.68 units for EPC prevalence and 6.872 units (mM Trolox equivalents) in total 
anti-oxidant capacity.
DISCUSSION:
Although SHS is now recognized as a significant contributor to cardiovascular risks in older 
age groups, the toddler population has not been studied. The characteristics of the children 
we enrolled match a population of very high concern for SHS exposure (urban, African 
American, low-income)24. More than half of the study participants lived with one or more 
smokers, and many of the participants had hair nicotine levels equivalent to published values 
associated with adult active smokers. This subgroup of US children is of very high concern 
regarding SHS exposure and later tobacco consumption and related disease risks.
In the present study, we evaluated an array of cardiovascular risk markers that encompassed 
clinical measures (blood pressure, lipids, glucose metabolism, inflammation) as well as three 
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recognized aspects of tobacco-related mechanisms of injury in adults, ‘research measures’ - 
(oxidation, vascular endothelial injury, and vascular repair). The apparently healthy toddler 
cohort had a wide range of values in these biomarkers. SHS exposure was independently 
linked to higher systolic blood pressure, HDL reduction, CRP elevation (a marker of 
inflammation), TAC reduction (a marker of oxidation) and EPC reduction (a marker of 
vascular repair). These relationships are all mechanistically relevant and apparently 
occurring simultaneously at a very young age. To our knowledge, this is one of the first 
studies to investigate the link between SHS exposure and cardiovascular disease risk in 
toddlers. These data extend prior work on the cardiovascular effects of tobacco exposure to a 
younger age group than previously studied.
Our findings demonstrate that health disparities noted during adulthood may at least be 
partially accounted for by early life SHS exposure. Epidemiological studies have shown the 
association between low socio-economic status during childhood and increased 
cardiovascular morbidity and mortality during adult life25. The lifetime health burden of 
youth who are SHS-exposed is bound to be significant. For example, a recent analysis of the 
Bogalusa Heart Study has shown that SHS exposure during childhood only showed a 
stronger association with cardiovascular risk than exposure in adulthood only26, suggesting 
an ‘imprinting effect’ of SHS-related disease risks. In addition to cumulative effects of years 
of exposure, children who grow up with smokers also are at greater risk of becoming active 
smokers due to the parental modeling of smoking behavior27. Obesity prevalence also varies 
inversely with SES28, and we noted an independent relationship between BMI z-score and 
systolic blood pressure and lower HDL among this group. Our goal should be to enhance our 
identification of the most-at-risk children and develop effective strategies to intervene and 
prevent adult cardiovascular disease.
One strength of this study is the focus on highly exposed, low-income, city-dwelling, 
children that may be the most vulnerable to physiological perturbations of SHS exposure. A 
convenience sample rather that a random or epidemiologically based sample is a potential 
limitation of this study, but we have no reason to believe that the relationships between SHS 
and outcomes investigated would be different due to sampling technique. We controlled for 
potential confounders including age, race, maternal education, method of payment, and BMI 
z-score, and acknowledge that this was a cross-sectional study, from which we can infer 
correlation but not causation. However, our findings are biologically plausible and align with 
previous data from older children, teens, and adults.
Another potential limitation is that we excluded children with persistent asthma. This 
exclusion would have biased our findings toward the null by excluding children with the 
most inflammation so that we may have underestimated the relationships between SHS and 
inflammation. Studies to understand the complete picture of cardiopulmonary risks and 
disease course patterns are needed, especially in young children.
In a very recent scientific statement, the American Heart Association has concluded that 
SHS is a compelling threat to cardiovascular health in children and that current evidence 
warrants “…a robust public health policy that embraces zero tolerance of childhood SHS 
exposure.” Our study supports this view since we found an objectively measured marker of 
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SHS (hair nicotine) was correlated to several variables already well-established as 
cardiovascular risk markers in adults. The fact that these relationships have been detected in 
toddlers, several decades before typical symptomatic heart disease, is alarming and may help 
to catalyze actions to enhance protection of young children from tobacco-related disease 
risks.
Supplementary Material
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Table 1:
Demographic data (n=139)
Subject Characteristics Mean ± SD or N(%)
Age, years 3.22 ± 1.06
Female 76 (55%)
Race
 African-American 76 (54.68%)
 White 32 (23.02%)
 Multi-racial 24 (17.27%)
 Other 7 (5.03%)
Ethnicity
 Hispanic or Latino 12 (8.63%)
Family Economic Status
 Subject insured by Medicaid, n (%) 122 (82%)
Maternal Education, n (%)
  Less than high school 44 (31.65%)
  High school or GED 35 (25.18%)
  Some college 41 (29.50%)
  College graduate 19 (13.67%)
Mean ± SD or median (range)
SHS exposure: hair nicotine (ng/mg) 5.51 ± 8.43
Hair nicotine median, range (ng/mg) 1.86 (0.025 – 39.45)
BMI, kg/m2 16.98 ± 2.28
BMI, z-score 0.90 ± 1.39
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Table 2.
Measured variables
Mean ± SD Sample N
Normally distributed variables
Systolic Blood Pressure, mm Hg 95.59 ± 10.53 131
Diastolic Blood Pressure, mm Hg 59.70 ± 8.21 131
Systolic Blood Pressure, % 59.77 ± 27.98 131
Diastolic Blood Pressure, % 74.83 ± 20.00 131
Total Cholesterol, mg/dL 146.46 ± 26.82 139
Low Density Lipoprotein, mg/dL 84.35 ± 23.58 139
High Density Lipoprotein, mg/dL, 48.73 ± 13.28 139
Fasting blood glucose, mg/dl 80.68 ± 7.28 139
Total anti-oxidant capacity, mm Trolox equivalent 102.59 ± 22.65 138
Soluble ICAM-1, ng/mL 206.89 ± 64.96 138
Median (IQR)
Skewed distribution variables
Fasting insulin, uIU/mL 6.46 (5.33–8.33) 138
C-Reactive Protein, mg/L 0.22 (0.04–1.27) 138
Interleukin-6, ng/L 13.31 (4.69–113.70) 138
TNF-α, ng/L 148.66 (76.54–1026.86) 138
Plasma protein malondialdehyde, pmol MDA/mL 18.8 (15.1–22.8) 138
Circulating CD34+ Cells, % of total events 0.0086 (0.0042–0.0156) 122
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3.
Multivariate Linear Regression Analysis of Associations with Logarithmically Transformed Hair Nicotine 
Levels
Log Hair Nicotine
Outcome Model N b SE b P
Systolic blood pressure 139 4.68 1.84 .013
Systolic blood pressure % 139 15.32 5.21 .004
CRP 138 0.92 0.35 .012
HDL 139 −4.42 1.82 .017
Total anti-oxidant capacity 138 −6.72 3.08 .032
EPC prevalence 122 −0.39 0.17 .028
Notes: Each row represents a separate regression model. Each regression model is adjusted for sex, age, race, ethnicity, insurance payment, 
maternal education, and BMI z-score is clustered on family ID and robust standard errors.
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